Examples of using Split virion in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Pandemic influenza vaccine(H1N1) split virion, inactivated, adjuvanted.
Vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmith Kline Biologicals.
Pandemrix suspension andemulsion for emulsion for injection Pandemic influenza vaccine(H5N1) split virion, inactivated, adjuvanted.
PREPANDEMIC INFLUENZA VACCINE(H5N1)(SPLIT VIRION, INACTIVATED, ADJUVANTED) GLAXOSMITHKLINE BIOLOGICALS.
A minor infection such as a cold should not be a problem, but your doctor will advise whether you can stillbe vaccinated with Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg.
What Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg contains.
If you have not previously received doses of Prepandrix or Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg.
Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg consists of two containers.
The potential benefits to the mother and risks to the infant should beconsidered before administering Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg during lactation.
Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg should not be given.
On the basis of the scientific conclusions for Pumarix, the CHMP is of the opinion that the benefit- risk balance of the medicinal product containing the activesubstance purified antigen fractions of inactivated split virion A/Indonesia/05/2005(H5N1)/PR8-IBCDC-RG2 is favourable subject to the proposed changes to the product information.
What Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg looks like and contents of the pack.
If you take any medicines that reduce immunity to infections or have any other type of treatment(such as radiotherapy) that affects the immune system,Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg can still be given but your response to the vaccine may be poor.
Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg should be used in accordance with official guidance.
Immune response against vaccinestrain contained in Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg.
Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg should under no circumstances be administered intravascularly or intradermally.
In a consistency study, more than 900 subjects aged 18-60years received Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg following a 0, 21 days schedule.
Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg suspension for emulsion for injection Prepandemic influenza vaccine H5N1.
The European Commission granted a marketing authorisation valid throughout theEU for‘ Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals' to GlaxoSmithKline Biologicals S. A. on 26 September 2008.
Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg suspension and emulsion for emulsion for injection Prepandemic influenza vaccine(H5N1) split virion, inactivated, adjuvanted.
You will receive two doses of Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg.
Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals' is a vaccine for use in adults aged between 18 and 60 years to protect against flu caused by the H5N1 strain(type) of the influenza A virus.
Take special care with Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg.
PSUR submission when Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg is used during the influenza pandemic.
One pack of Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg consists of.
The volume of Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg(5 ml) after mixing corresponds to 10 doses of vaccine.
In the first few weeks after vaccination with Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg the results of these tests may not be correct.
No data have been generated in pregnant women with Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg or with any other vaccine that contains the AS03 adjuvant.
If you have previously had a sudden life-threatening allergicreaction to any ingredient of Prepandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg(these are listed at the end of this leaflet) or to any of the substances that may be present in trace amounts as follows: egg and chicken protein, ovalbumin.